Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.

Analogues of the naturally occurring cyclic hydroxamate dealanylalahopcin, which is an inhibitor of procollagen prolyl-4-hydroxylase, were synthesised and shown to be inhibitors of the human hypoxia-inducible factor prolyl hydroxylases.

Detaylı Bibliyografya
Asıl Yazarlar:	Schlemminger, I, Mole, D, McNeill, L, Dhanda, A, Hewitson, K, Tian, Y, Ratcliffe, P, Pugh, C, Schofield, C
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2003

Benzer Materyaller

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
Yazar:: Mole, D, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
Yazar:: McNeill, L, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
Yazar:: Tuckerman, JR, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Regulation of HIF: prolyl hydroxylases.
Yazar:: Stolze, I, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
Yazar:: Chan, M, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.
Yazar:: Yeoh, K, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
Yazar:: Yeh, TL, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation.
Yazar:: Tian, Y, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
Yazar:: Chowdhury, R, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

2-Oxoglutarate analogue inhibitors of prolyl hydroxylase domain 2.
Yazar:: Mecinović, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
Yazar:: Hewitson, K, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alpha.
Yazar:: Elkins, J, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
Yazar:: Holt-Martyn, JP, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

ENANTIOSPECIFIC SYNTHESIS OF DEALANYLALAHOPCIN
Yazar:: Baldwin, J, ve diğerleri
Baskı/Yayın Bilgisi: (1990)

STEREOSPECIFIC SYNTHESIS OF DEALANYLALAHOPCIN
Yazar:: Baldwin, J, ve diğerleri
Baskı/Yayın Bilgisi: (1990)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
Yazar:: Cockman, M, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Inhibition of hypoxia inducible factor (HIF) hydroxylases
Yazar:: Conejo-Garcia, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
Yazar:: Chowdhury, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
Yazar:: Rasheduzzaman Chowdhury, ve diğerleri
Baskı/Yayın Bilgisi: (2016-08-01)

The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin.
Yazar:: Masson, N, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family.
Yazar:: Hewitson, K, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
Yazar:: Matthew E Cockman, ve diğerleri
Baskı/Yayın Bilgisi: (2019-09-01)

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.
Yazar:: Epstein, A, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation.
Yazar:: Willam, C, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
Yazar:: Masson, N, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Oxygen sensing by HIF hydroxylases.
Yazar:: Schofield, C, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Signalling hypoxia by HIF hydroxylases.
Yazar:: Schofield, C, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
Yazar:: Andrey A. Poloznikov, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

A fluorescent benzo[g]isoquinoline-based HIF prolyl hydroxylase inhibitor for cellular imaging
Yazar:: Mayer, M, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia
Yazar:: Takahiro Kambara, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
Yazar:: Kiichi Hirota
Baskı/Yayın Bilgisi: (2021-04-01)

Iron homeostasis and its interaction with prolyl hydroxylases.
Yazar:: Mole, D
Baskı/Yayın Bilgisi: (2010)

Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors induce autophagy and have a protective effect in an in-vitro ischaemia model
Yazar:: Singh, A, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Hypoxia-inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate.
Yazar:: McNeill, L, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.
Yazar:: Chen, R, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice
Yazar:: Chen, R, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
Yazar:: Flashman, E, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility.
Yazar:: Astuti, D, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Mutation Analysis of HIF-prolyl hydroxylases (PHD/EGLN) in Inherited Phaeochromocytoma and Renal Cell Carcinoma
Yazar:: Astuti, D, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses
Yazar:: Moritz J. Strowitzki, ve diğerleri
Baskı/Yayın Bilgisi: (2021-04-01)